Immunohistochemical analysis of SOX2 expression in small-cell neuroendocrine carcinoma of the endometrium

Small-cell neuroendocrine carcinoma (NEC) of the endometrium is an extremely rare and highly aggressive carcinoma. Sex-determining region Y-box 2 (SOX2) is a master transcription factor regulating the self-renewal, maintenance of stem cell properties and pluripotency of embryonic stem cells, and recent studies revealed that SOX2 plays important roles in cancer growth and progression in several types of carcinomas, including small-cell neuroendocrine carcinoma (NEC) of the lung and oesophagus. Few studies to date have analysed the association between SOX2 and endometrioid carcinoma, whereas the expression of SOX2 in small-cell NEC of the endometrium has not been investigated. The aim of the present study was to analyse the expression status of SOX2, p16 and paired-box gene (PAX) 8, a useful Müllerian marker, in endometrial small-cell NEC. A total of 4 patients with small-cell NEC of the endometrium were enrolled (median age, 70 years). Immunohistochemical studies revealed SOX2 expression in 3 patients and p16 expression in all patients. No patients exhibited positive immunoreactivity for PAX8. SOX2 expression has been reported to be associated with the pathogenesis of small-cell NEC of the oesophagus. Therefore, the results of the present study indicated that SOX2 expression plays an important role in the development of small-cell NEC of the endometrium and the oesophagus. Moreover, expression of p16 and loss of PAX8 do not indicate the origin of small-cell NEC of the endometrium.

[1]  K. Tsuta,et al.  Small‐cell neuroendocrine carcinoma in directly sampled endometrial cytology: A monocentric retrospective study of six cases , 2019, Diagnostic cytopathology.

[2]  H. Mohammadpour,et al.  Association of High Expression Levels of SOX2, NANOG, and OCT4 in Gastric Cancer Tumor Tissues with Progression and Poor Prognosis , 2019, Journal of Gastrointestinal Cancer.

[3]  Peng-Hui Wang,et al.  Crosstalk between SOX2 and cytokine signaling in endometrial carcinoma , 2018, Scientific Reports.

[4]  K. Yoshihara,et al.  Sox2‐dependent inhibition of p21 is associated with poor prognosis of endometrial cancer , 2017, Cancer science.

[5]  Yoichi Tanaka,et al.  SOX2 and Rb1 in esophageal small-cell carcinoma: their possible involvement in pathogenesis , 2017, Modern Pathology.

[6]  I. Takemasa,et al.  SOX2 and ALDH1 as Predictors of Operable Breast Cancer. , 2016, Anticancer research.

[7]  A. Malpica,et al.  Neuroendocrine Carcinoma of the Endometrium: A Clinicopathologic Study of 25 Cases , 2016, The American journal of surgical pathology.

[8]  K. Okoń,et al.  SOX-2, but not Oct4, is highly expressed in early-stage endometrial adenocarcinoma and is related to tumour grading. , 2015, International journal of clinical and experimental pathology.

[9]  H. Okabe,et al.  Small cell carcinoma of the endometrium: a case report with emphasis on the cytological features. , 2014, International journal of clinical and experimental pathology.

[10]  M. D'Amico,et al.  SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells , 2014, Oncogene.

[11]  L. Bujanda,et al.  Embryonic stem cell factors and pancreatic cancer. , 2014, World journal of gastroenterology.

[12]  H. Ueda,et al.  Context-dependent wiring of Sox2 regulatory networks for self-renewal of embryonic and trophoblast stem cells. , 2013, Molecular cell.

[13]  H. Asamura,et al.  Expression of Squamous Cell Carcinoma Markers and Adenocarcinoma Markers in Primary Pulmonary Neuroendocrine Carcinomas , 2013, Applied immunohistochemistry & molecular morphology : AIMM.

[14]  N. Ordóñez.  Value of PAX 8 Immunostaining in Tumor Diagnosis: A Review and Update , 2012, Advances in anatomic pathology.

[15]  K. Busam,et al.  An Immunohistochemical Study of Cervical Neuroendocrine Carcinomas: Neoplasms That are Commonly TTF1 Positive and Which May Express CK20 and P63 , 2010, The American journal of surgical pathology.

[16]  J. Hornick,et al.  Sox2 Expression in Pulmonary Non-small Cell and Neuroendocrine Carcinomas , 2010, Applied immunohistochemistry & molecular morphology : AIMM.

[17]  I. Shih,et al.  Utility of p16 Expression for Distinction of Uterine Serous Carcinomas From Endometrial Endometrioid and Endocervical Adenocarcinomas: Immunohistochemical Analysis of 201 Cases , 2009, The American journal of surgical pathology.